Plain-English translation of NCT06787612 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Ovarian Cancer research guide →Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a new medication called , which works by helping your immune system fight cancer cells. Researchers want to see how safe and effective this medication is on its own, and also when combined with other cancer treatments. The study focuses on people with advanced ovarian cancer that has progressed despite previous platinum-based chemotherapy.
Ovarian cancer that becomes resistant to platinum drugs is very difficult to treat, and patients need new treatment options. This medication uses a novel approach by connecting cancer cells directly to immune cells, potentially helping your body's natural defenses fight the cancer more effectively.
You likely qualify if…
You likely don't qualify if…
You would receive the study medication either alone or in combination with other anti-cancer drugs, depending on which study group you're assigned to. You'll have regular clinic visits to receive treatment, have blood drawn to check how much medication is in your system and how your body is responding, and have imaging scans to see if your cancer is shrinking. The study team will closely monitor you for any side effects throughout your participation.
AI-generated summary from trial data · Aug 19, 2026 · Not medical advice
United States